223 related articles for article (PubMed ID: 38013157)
21. The current state of food allergy therapeutics.
Chen M; Land M
Hum Vaccin Immunother; 2017 Oct; 13(10):2434-2442. PubMed ID: 28846472
[TBL] [Abstract][Full Text] [Related]
22. Biologics in food allergy: up-to-date.
Passanisi S; Caminiti L; Zirilli G; Lombardo F; Crisafulli G; Aversa T; Pajno GB
Expert Opin Biol Ther; 2021 Sep; 21(9):1227-1235. PubMed ID: 33733975
[No Abstract] [Full Text] [Related]
23. New Developments in Non-allergen-specific Therapy for the Treatment of Food Allergy.
Long A; Borro M; Sampath V; Chinthrajah RS
Curr Allergy Asthma Rep; 2020 Jan; 20(1):3. PubMed ID: 31950290
[TBL] [Abstract][Full Text] [Related]
24. Retail Food Equivalents for Post-Oral Immunotherapy Dosing in the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy in Food-Allergic Children and Adults (OUtMATCH) Clinical Trial.
Groetch M; Mudd K; Woch M; Schaible A; Gray BE; Babineau DC; Bird JA; Jones S; Kim EH; Lanser BJ; Poyser J; Rogers N; Shreffler W; Sicherer S; Spergel AKR; Spergel J; Vickery BP; Chinthrajah RS; Wood R
J Allergy Clin Immunol Pract; 2023 Feb; 11(2):572-580.e2. PubMed ID: 37113037
[TBL] [Abstract][Full Text] [Related]
25. How to actively treat food allergy.
Pecora V; Mennini M; Calandrelli V; Patriarca G; Valluzzi R; Fierro V
Curr Opin Allergy Clin Immunol; 2018 Jun; 18(3):248-257. PubMed ID: 29629957
[TBL] [Abstract][Full Text] [Related]
26. Oral Immunotherapy for Food Allergy.
Wood RA
J Investig Allergol Clin Immunol; 2017; 27(3):151-159. PubMed ID: 28102823
[TBL] [Abstract][Full Text] [Related]
27. Exploring novel approaches to food allergy management.
Howard-Ruben J; Doucette J
J Am Assoc Nurse Pract; 2023 Dec; 35(12):843-852. PubMed ID: 37335848
[TBL] [Abstract][Full Text] [Related]
28. Allergen-specific oral immunotherapy for peanut allergy.
Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
[TBL] [Abstract][Full Text] [Related]
29. Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab.
Manohar M; Dunham D; Gupta S; Yan Z; Zhang W; Minnicozzi S; Kirkey M; Bunning B; Roy Chowdhury R; Galli SJ; Boyd SD; Kost LE; Chinthrajah RS; Desai M; Oettgen HC; Maecker HT; Yu W; DeKruyff RH; Andorf S; Nadeau KC
Allergy; 2021 Sep; 76(9):2809-2826. PubMed ID: 33782956
[TBL] [Abstract][Full Text] [Related]
30. Food oral immunotherapy: Any distinguishing factors predicting the need of anti-IgE?
Akarcan SE; Şenol HD; Gülen F; Demir E
Allergol Immunopathol (Madr); 2023; 51(6):104-111. PubMed ID: 37968804
[TBL] [Abstract][Full Text] [Related]
31. Oral immunotherapy with omalizumab reverses the Th2 cell-like programme of regulatory T cells and restores their function.
Abdel-Gadir A; Schneider L; Casini A; Charbonnier LM; Little SV; Harrington T; Umetsu DT; Rachid R; Chatila TA
Clin Exp Allergy; 2018 Jul; 48(7):825-836. PubMed ID: 29700872
[TBL] [Abstract][Full Text] [Related]
32. Clinical studies in oral allergen-specific immunotherapy: differences among allergens.
Sato S; Yanagida N; Ogura K; Imai T; Utsunomiya T; Iikura K; Goto M; Asaumi T; Okada Y; Koike Y; Syukuya A; Ebisawa M
Int Arch Allergy Immunol; 2014; 164(1):1-9. PubMed ID: 24943470
[TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.
Wood RA; Kim JS; Lindblad R; Nadeau K; Henning AK; Dawson P; Plaut M; Sampson HA
J Allergy Clin Immunol; 2016 Apr; 137(4):1103-1110.e11. PubMed ID: 26581915
[TBL] [Abstract][Full Text] [Related]
34. Clinical aspects of oral immunotherapy for the treatment of allergies.
Yanagida N; Sato S; Ebisawa M
Semin Immunol; 2017 Apr; 30():45-51. PubMed ID: 28780220
[TBL] [Abstract][Full Text] [Related]
35. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.
Schneider LC; Rachid R; LeBovidge J; Blood E; Mittal M; Umetsu DT
J Allergy Clin Immunol; 2013 Dec; 132(6):1368-74. PubMed ID: 24176117
[TBL] [Abstract][Full Text] [Related]
36. Oral Immunotherapy for Food Allergy.
Burbank AJ; Sood P; Vickery BP; Wood RA
Immunol Allergy Clin North Am; 2016 Feb; 36(1):55-69. PubMed ID: 26617227
[TBL] [Abstract][Full Text] [Related]
37. The use of omalizumab in allergen immunotherapy.
Dantzer JA; Wood RA
Clin Exp Allergy; 2018 Mar; 48(3):232-240. PubMed ID: 29315922
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy for Food Allergy: Are We There Yet?
Gernez Y; Nowak-Węgrzyn A
J Allergy Clin Immunol Pract; 2017; 5(2):250-272. PubMed ID: 28283151
[TBL] [Abstract][Full Text] [Related]
39. Double-Blind, Placebo-Controlled Study of E-B-FAHF-2 in Combination With Omalizumab-Facilitated Multiallergen Oral Immunotherapy.
Wang J; Wood RA; Raymond S; Suárez-Fariñas M; Yang N; Sicherer SH; Sampson HA; Li XM
J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2208-2216.e1. PubMed ID: 37087097
[TBL] [Abstract][Full Text] [Related]
40. The Heterogeneity of Oral Immunotherapy Clinical Trials: Implications and Future Directions.
Yee CS; Rachid R
Curr Allergy Asthma Rep; 2016 Apr; 16(4):25. PubMed ID: 26922433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
